CPHRF Stock CPHRF is expected to report earnings to fall -70% to 8 cents per share on March 14

A.I.dvisor
at Tickeron.com
03/13/24
Loading...
CPHRF - Cipher Pharmaceuticals
Cipher Pharmaceuticals Earnings Graph
Q4'23
Est.
$0.08
Q3'23
Beat
by $0.20
Q2'23
Beat
by $0.03
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.69
The last earnings report on September 30 showed earnings per share of 27 cents, beating the estimate of 7 cents. P/B Ratio (1.400) is normal, around the industry mean (49.285). P/E Ratio (3.587) is within average values for comparable stocks, (90.096). CPHRF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.691). CPHRF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (5.473) is also within normal values, averaging (66.318). With 51.38K shares outstanding, the current market capitalization sits at 110.31M.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
5750 Explorer Drive
Phone
+1 905 602-5840
Employees
5
Web
https://www.cipherpharma.com